Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Shinpoong Pharmaceutical (019170 KS)
Watchlist
79
Analysis
Health Care
•
South Korea
Shin Poong Pharmaceutical Co., Ltd. manufactures pharmaceutical raw materials and prescription drugs, such as cephalosporin antibiotics, hemostatics, sedative agents, and anti-diabetics.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
APR
•
28 May 2024 04:39
An Early Look at Potential Deletions and Additions to KOSPI200 in December 2024
We provide an early look at the potential additions and deletions to KOSPI200 rebalance in December 2024. The seven potential additions are up on...
Douglas Kim
Follow
605 Views
Share
bullish
•
Hanmi Semiconductor
•
24 May 2024 21:42
KOSPI200 June '24 Rebalance: Index Changes Released, 6 Additions & 6 Deletions
The KRX have released the index changes for the KOSPI200 June review. The index will be rebalanced in the closing auction on Thursday the 13th of...
DMA
Follow
778 Views
Share
bullish
•
SeAH Steel Holdings
•
07 May 2024 18:00
Quiddity Leaderboard KOSPI 200 Jun 24: One Last-Minute Change to Rankings
The KOSPI 200 rebal reference period is now finished. There is one change to our expectations for the June 2024 index review based on a share...
Travis Lundy
Follow
566 Views
Share
bullish
•
Mini Kospi 200 Futures
•
06 May 2024 08:20
Addressing Areas of Confusion Surrounding the KOSPI 200 June Rebalancing
This post aims to provide clarity on several aspects of confusion surrounding the KOSPI 200 regular rebalancing in June.
Sanghyun Park
Follow
603 Views
Share
bullish
•
Hanmi Semiconductor
•
02 May 2024 05:25
KOSPI200 Index Rebalance Preview: 5-6 Changes Possible from Now to June
There could be 5-6 changes for the KOSPI200 from now to June. Watch for the HD Hyundai Marine listing too. Impact is between 5-15x ADV and there...
Brian Freitas
Follow
712 Views
Share
First
Previous
1
2
3
4
5
6
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x